Phase I study of HM12525A in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 18 Sep 2015
At a glance
- Drugs HM 12525A (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 05 Jun 2015 New trial record
- 03 Jun 2015 Results of this study will be presented at the American Diabetes Association's 75th Scientific Sessions, according to a Hanmi Pharmaceutical media release.